J.P. Morgan Chase & Co. has an Overweight rating on Illumina, Inc. ILMN, but raised the price target to $68 from $57.
Shares of ILMN gained $1.00 yesterday to close at $64.34.
Market News and Data brought to you by Benzinga APIs© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
Comments
Loading...
date | ticker | name | Price Target | Upside/Downside | Recommendation | Firm |
---|
Posted In: Analyst ColorPrice TargetAnalyst RatingsHealth CareJ.P. Morgan Chase & Co.Life Sciences Tools & Services
Benzinga simplifies the market for smarter investing
Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.
Join Now: Free!
Already a member?Sign in